
Grand Rounds - Alzheimer's Disease: New Frontiers in Diagnosis and Therapy - Live
This activity focuses on the latest advancements in the diagnostics and therapeutics of Alzheimer’s dementia. Key topics include the continuum of Alzheimer’s disease, biomarkers for early detection, revised diagnostic criteria, pharmacological management, and emerging disease-modifying therapies.
Target Audience
- Physicians
- Physician Assistants
- Advanced Practice Nurses
- Registered Nurses
- Licensed Practical Nurses
Learning Objectives
Learners will be able to:
- Define dementia and mild cognitive impairment and describe the Alzheimer’s disease continuum.
- Identify key biomarkers used in the early detection and diagnosis of Alzheimer’s disease.
- Summarize revised diagnostic criteria for Alzheimer’s dementia in clinical practice.
- Discuss current and emerging pharmacological treatments, including anti-amyloid therapies.
- Recognize and manage potential adverse effects related to new therapeutics, such as ARIA
Pallavi Joshi, DO
Debra Chionis, MS, ACE-MES, ACSM-CEP
Lino Linares, DO
Caitlyn Boyd, MHA, MSN, RN, CPHQ, CPAHA-TeleStroke
Muhammad Saeed, Bcom
This activity has been submitted to the Emergency Nurses Association for approval to award contact hours. The Emergency Nurses Association is accredited as an approver of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
TeleSpecialists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
TeleSpecialists designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.